Study of Human Recombinant GM-CSF Produced in Different Host Systems Using Monoclonal Antibodies View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2002

AUTHORS

M. Etcheverrigaray , M. Oggero , M. Bollati , R. Kratje

ABSTRACT

GM-CSF is a glycoprotein that activates growth and differentiation of hemopoietic progenitor cells, usefull to reverse or prevent chemotherapy secondary leukopenias. In spite of the differences in the chemical structure, due to the variable glycosydic content of the forms produced in bacteria, yeast and mammalian cells, all of them have biological activity. Independently, antigenicity of non glycosylated recombinant human proteins may have relevance in the choice of the host system for the production of factors for clinical use.To study the undesirable immune response in the results of the therapy, we used the following strategy: i) To obtain the glycosylated hormone, CHO dhfr− cells were manipulated by genetic methods to produce human GM-CSF under the control of the adenovirus major late promoter. ii) A panel of GM-CSF MAbs was produced from hybridoma cells obtained in our lab. We analyzed the specificity of the MAbs taking into account their neutralizing capacity. Some of them neutralized the in vitro biological activity of the hormone, with different affinities for GM-CSF from several sources. Patients under treatment with the commercial non-glycosylated GM-CSF develop antibodies and undesirable responses. Competition experiments between the neutralizing MAbs and these human antibodies would demonstrate the importance of the immune response in the choice of the host system for its production. More... »

PAGES

163-165

Book

TITLE

New Developments and New Applications in Animal Cell Technology

ISBN

0-7923-5016-2

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/0-306-46860-3_29

DOI

http://dx.doi.org/10.1007/0-306-46860-3_29

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041894326


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National University of the Littoral", 
          "id": "https://www.grid.ac/institutes/grid.10798.37", 
          "name": [
            "Instituto de Tecnolog\u00eda Biol\u00f3gica (INTEBIO). Facultad de Bioqu\u00edmica y Ciencias Biol\u00f3gicas, Universidad Nacional del Litoral Ciudad Universitaria, C.C. 530 - (3000)\u00a0Santa Fe., Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Etcheverrigaray", 
        "givenName": "M.", 
        "id": "sg:person.01133021710.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133021710.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of the Littoral", 
          "id": "https://www.grid.ac/institutes/grid.10798.37", 
          "name": [
            "Instituto de Tecnolog\u00eda Biol\u00f3gica (INTEBIO). Facultad de Bioqu\u00edmica y Ciencias Biol\u00f3gicas, Universidad Nacional del Litoral Ciudad Universitaria, C.C. 530 - (3000)\u00a0Santa Fe., Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Oggero", 
        "givenName": "M.", 
        "id": "sg:person.01156276723.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156276723.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of the Littoral", 
          "id": "https://www.grid.ac/institutes/grid.10798.37", 
          "name": [
            "Instituto de Tecnolog\u00eda Biol\u00f3gica (INTEBIO). Facultad de Bioqu\u00edmica y Ciencias Biol\u00f3gicas, Universidad Nacional del Litoral Ciudad Universitaria, C.C. 530 - (3000)\u00a0Santa Fe., Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bollati", 
        "givenName": "M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of the Littoral", 
          "id": "https://www.grid.ac/institutes/grid.10798.37", 
          "name": [
            "Instituto de Tecnolog\u00eda Biol\u00f3gica (INTEBIO). Facultad de Bioqu\u00edmica y Ciencias Biol\u00f3gicas, Universidad Nacional del Litoral Ciudad Universitaria, C.C. 530 - (3000)\u00a0Santa Fe., Argentina"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kratje", 
        "givenName": "R.", 
        "id": "sg:person.01064706510.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064706510.72"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90665-r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006943080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(90)90665-r", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006943080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1365-2249.1996.11704.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033487873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081377198", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002", 
    "datePublishedReg": "2002-01-01", 
    "description": "GM-CSF is a glycoprotein that activates growth and differentiation of hemopoietic progenitor cells, usefull to reverse or prevent chemotherapy secondary leukopenias. In spite of the differences in the chemical structure, due to the variable glycosydic content of the forms produced in bacteria, yeast and mammalian cells, all of them have biological activity. Independently, antigenicity of non glycosylated recombinant human proteins may have relevance in the choice of the host system for the production of factors for clinical use.To study the undesirable immune response in the results of the therapy, we used the following strategy: i) To obtain the glycosylated hormone, CHO dhfr\u2212 cells were manipulated by genetic methods to produce human GM-CSF under the control of the adenovirus major late promoter. ii) A panel of GM-CSF MAbs was produced from hybridoma cells obtained in our lab. We analyzed the specificity of the MAbs taking into account their neutralizing capacity. Some of them neutralized the in vitro biological activity of the hormone, with different affinities for GM-CSF from several sources. Patients under treatment with the commercial non-glycosylated GM-CSF develop antibodies and undesirable responses. Competition experiments between the neutralizing MAbs and these human antibodies would demonstrate the importance of the immune response in the choice of the host system for its production.", 
    "editor": [
      {
        "familyName": "Merten", 
        "givenName": "Otto-Wilhelm", 
        "type": "Person"
      }, 
      {
        "familyName": "Perrin", 
        "givenName": "Pierre", 
        "type": "Person"
      }, 
      {
        "familyName": "Griffiths", 
        "givenName": "Bryan", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/0-306-46860-3_29", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "0-7923-5016-2"
      ], 
      "name": "New Developments and New Applications in Animal Cell Technology", 
      "type": "Book"
    }, 
    "name": "Study of Human Recombinant GM-CSF Produced in Different Host Systems Using Monoclonal Antibodies", 
    "pagination": "163-165", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/0-306-46860-3_29"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c790d313215735ba0121e5fef3fd5652327efd8e9effc34ddf9bc9967f2d007c"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041894326"
        ]
      }
    ], 
    "publisher": {
      "location": "Dordrecht", 
      "name": "Kluwer Academic Publishers", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/0-306-46860-3_29", 
      "https://app.dimensions.ai/details/publication/pub.1041894326"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-15T18:13", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8681_00000269.jsonl", 
    "type": "Chapter", 
    "url": "http://link.springer.com/10.1007/0-306-46860-3_29"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/0-306-46860-3_29'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/0-306-46860-3_29'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/0-306-46860-3_29'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/0-306-46860-3_29'


 

This table displays all metadata directly associated to this object as RDF triples.

102 TRIPLES      23 PREDICATES      30 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/0-306-46860-3_29 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Nf79f6e5709724cdba41a40e6109e4b8a
4 schema:citation https://app.dimensions.ai/details/publication/pub.1081377198
5 https://doi.org/10.1016/0140-6736(90)90665-r
6 https://doi.org/10.1046/j.1365-2249.1996.11704.x
7 schema:datePublished 2002
8 schema:datePublishedReg 2002-01-01
9 schema:description GM-CSF is a glycoprotein that activates growth and differentiation of hemopoietic progenitor cells, usefull to reverse or prevent chemotherapy secondary leukopenias. In spite of the differences in the chemical structure, due to the variable glycosydic content of the forms produced in bacteria, yeast and mammalian cells, all of them have biological activity. Independently, antigenicity of non glycosylated recombinant human proteins may have relevance in the choice of the host system for the production of factors for clinical use.To study the undesirable immune response in the results of the therapy, we used the following strategy: i) To obtain the glycosylated hormone, CHO dhfr− cells were manipulated by genetic methods to produce human GM-CSF under the control of the adenovirus major late promoter. ii) A panel of GM-CSF MAbs was produced from hybridoma cells obtained in our lab. We analyzed the specificity of the MAbs taking into account their neutralizing capacity. Some of them neutralized the in vitro biological activity of the hormone, with different affinities for GM-CSF from several sources. Patients under treatment with the commercial non-glycosylated GM-CSF develop antibodies and undesirable responses. Competition experiments between the neutralizing MAbs and these human antibodies would demonstrate the importance of the immune response in the choice of the host system for its production.
10 schema:editor N13376e6c9f8b4bbbba349fa6955264ba
11 schema:genre chapter
12 schema:inLanguage en
13 schema:isAccessibleForFree false
14 schema:isPartOf Nd85f2c215efd4f0783e9ceac2a35a7ab
15 schema:name Study of Human Recombinant GM-CSF Produced in Different Host Systems Using Monoclonal Antibodies
16 schema:pagination 163-165
17 schema:productId N5343e24004cd4f1cb2eaa49fbfa45f72
18 N956f04cd71af41eba6f7fe57f2a80642
19 Ndd36c5bdc93d48c38479a8a419e92b2c
20 schema:publisher N71112a0ae8a74ef180c7911b53be3cc0
21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041894326
22 https://doi.org/10.1007/0-306-46860-3_29
23 schema:sdDatePublished 2019-04-15T18:13
24 schema:sdLicense https://scigraph.springernature.com/explorer/license/
25 schema:sdPublisher Nae7df3b3f3044b2a9ceec96ca4b8f147
26 schema:url http://link.springer.com/10.1007/0-306-46860-3_29
27 sgo:license sg:explorer/license/
28 sgo:sdDataset chapters
29 rdf:type schema:Chapter
30 N13376e6c9f8b4bbbba349fa6955264ba rdf:first N395ae8b6cebf46749a1ce4c12d4f0733
31 rdf:rest Nf2aa13e7dbad448d9eaa6f66a7e8749b
32 N26d34dbc8df34d52961f2ad108fb6ab8 schema:familyName Perrin
33 schema:givenName Pierre
34 rdf:type schema:Person
35 N395ae8b6cebf46749a1ce4c12d4f0733 schema:familyName Merten
36 schema:givenName Otto-Wilhelm
37 rdf:type schema:Person
38 N5091af6d8b894cf3b6ccd9fc0ebdf433 rdf:first sg:person.01156276723.63
39 rdf:rest Nec66373852854609b31c8dca96733657
40 N5343e24004cd4f1cb2eaa49fbfa45f72 schema:name doi
41 schema:value 10.1007/0-306-46860-3_29
42 rdf:type schema:PropertyValue
43 N6258dad20e964e7ba4d31a473497ea01 schema:affiliation https://www.grid.ac/institutes/grid.10798.37
44 schema:familyName Bollati
45 schema:givenName M.
46 rdf:type schema:Person
47 N651fc01f6964477ca57faefda54a350d rdf:first N828e2f19efee4409b38438db9476b801
48 rdf:rest rdf:nil
49 N71112a0ae8a74ef180c7911b53be3cc0 schema:location Dordrecht
50 schema:name Kluwer Academic Publishers
51 rdf:type schema:Organisation
52 N828e2f19efee4409b38438db9476b801 schema:familyName Griffiths
53 schema:givenName Bryan
54 rdf:type schema:Person
55 N82c4dbf565fd4f55b13703b2b554e8d3 rdf:first sg:person.01064706510.72
56 rdf:rest rdf:nil
57 N956f04cd71af41eba6f7fe57f2a80642 schema:name readcube_id
58 schema:value c790d313215735ba0121e5fef3fd5652327efd8e9effc34ddf9bc9967f2d007c
59 rdf:type schema:PropertyValue
60 Nae7df3b3f3044b2a9ceec96ca4b8f147 schema:name Springer Nature - SN SciGraph project
61 rdf:type schema:Organization
62 Nd85f2c215efd4f0783e9ceac2a35a7ab schema:isbn 0-7923-5016-2
63 schema:name New Developments and New Applications in Animal Cell Technology
64 rdf:type schema:Book
65 Ndd36c5bdc93d48c38479a8a419e92b2c schema:name dimensions_id
66 schema:value pub.1041894326
67 rdf:type schema:PropertyValue
68 Nec66373852854609b31c8dca96733657 rdf:first N6258dad20e964e7ba4d31a473497ea01
69 rdf:rest N82c4dbf565fd4f55b13703b2b554e8d3
70 Nf2aa13e7dbad448d9eaa6f66a7e8749b rdf:first N26d34dbc8df34d52961f2ad108fb6ab8
71 rdf:rest N651fc01f6964477ca57faefda54a350d
72 Nf79f6e5709724cdba41a40e6109e4b8a rdf:first sg:person.01133021710.19
73 rdf:rest N5091af6d8b894cf3b6ccd9fc0ebdf433
74 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
75 schema:name Medical and Health Sciences
76 rdf:type schema:DefinedTerm
77 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
78 schema:name Immunology
79 rdf:type schema:DefinedTerm
80 sg:person.01064706510.72 schema:affiliation https://www.grid.ac/institutes/grid.10798.37
81 schema:familyName Kratje
82 schema:givenName R.
83 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064706510.72
84 rdf:type schema:Person
85 sg:person.01133021710.19 schema:affiliation https://www.grid.ac/institutes/grid.10798.37
86 schema:familyName Etcheverrigaray
87 schema:givenName M.
88 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133021710.19
89 rdf:type schema:Person
90 sg:person.01156276723.63 schema:affiliation https://www.grid.ac/institutes/grid.10798.37
91 schema:familyName Oggero
92 schema:givenName M.
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01156276723.63
94 rdf:type schema:Person
95 https://app.dimensions.ai/details/publication/pub.1081377198 schema:CreativeWork
96 https://doi.org/10.1016/0140-6736(90)90665-r schema:sameAs https://app.dimensions.ai/details/publication/pub.1006943080
97 rdf:type schema:CreativeWork
98 https://doi.org/10.1046/j.1365-2249.1996.11704.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033487873
99 rdf:type schema:CreativeWork
100 https://www.grid.ac/institutes/grid.10798.37 schema:alternateName National University of the Littoral
101 schema:name Instituto de Tecnología Biológica (INTEBIO). Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral Ciudad Universitaria, C.C. 530 - (3000) Santa Fe., Argentina
102 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...